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Crystal Structure of the Dinuclear Zinc
Aminopeptidase PepV from Lactobacillus delbrueckii
Unravels Its Preference for Dipeptides
to degrade casein to small peptides and amino acids.
Since they are used as starter cultures in dairy fermenta-
tion, the quality of those dairy products depends on the
distribution of the product peptides and amino acids.
In view of the economic importance of those processes
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1Max-Planck-Institut fu¨r Biochemie
Abteilung Strukturforschung in the food industry, a better understanding of the pro-
teinases involved would be highly valuable, as it wouldAm Klopferspitz 18a
D-82152 Martinsried enable the development of genetically modified starter
strains with improved fermentation properties. Further-Germany
2 Unit for Structural Molecular Biology more, milk fermented by a Lactobacillus helveticus
strain has been reported to have antihypertensive prop-MPG-ASMB c/o DESY
22603 Hamburg erties, rendering it interesting as functional food [2].
Dipeptidases are involved in the final breakdown of3 Universita¨t Osnabru¨ck
Fachbereich Biologie/Chemie protein degradation fragments produced by other pepti-
dases and are thus important components of the proteinBarbarastraße 11
49069 Osnabru¨ck degradation system. Deletion of the dipeptidase pepV
gene from Lactococcus lactis resulted in significantlyGermany
4 De´partement d’Inge´nierie et d’Etudes des decreased growth rates but did not reduce the final cell
density [3]. The highly homologous PepV from Lactoba-Prote´ines
Centre d’Etudes Saclay cillus delbrueckii was originally described as a carnosi-
nase cleaving the unusual peptide -Ala-His (carnosine)91191 Gif-sur-Yvette Cedex
France [4]. It consists of a 470 residue polypeptide single chain
and has been characterized as a relatively unspecific5 Fachbereich Biologie
Abteilung Mikrobiologie dipeptidase cleaving a variety of dipeptides, notably
those with an N-terminal -Ala or D-Ala residue, but alsoUniversita¨t Kaiserslautern
Postfach 3049 catalyzing the removal of the N-terminal amino acid from
a few distinct tripeptides [5]. This capability led to theD-67653 Kaiserslautern
Germany assignment of PepV as an aminopeptidase in addition
to its predominant dipeptidase activity.
Interestingly, PepV is related not only to proteases
but also to acetylornithine deacetylase and succinyldi-Summary
aminopimelate desuccinylase, and has recently been
described as a member of the aminoacylase-1 family [6].PepV from Lactobacillus delbrueckii, a dinuclear zinc
peptidase, has been characterized as an unspecific These enzymes share the characteristics of hydrolyzing
amide bonds in a zinc- (or cobalt-) dependent manner.amino dipeptidase. The crystal structure of PepV in com-
plex with the phosphinic inhibitor Asp[PO2CH2]AlaOH, Classified as a peptidase, PepV belongs to the dinuclear
peptidase family M20 of clan MH [7, 8], which includesa dipeptide substrate mimetic, reveals a “catalytic do-
main” and a “lid domain,” which together form an inter- bacterial and yeast carboxypeptidases such as the glu-
tamate carboxypeptidases G1 and G2 (CPG1 and 2)nal active site cavity that traps the inhibitor. The catalytic
domain is topologically similar to catalytic domains from from Pseudomonas stutzeri and sp., a Gly-X carboxy-
peptidase from yeast, and several amino acid tripepti-amino- and carboxypeptidases. However, the lid do-
main is unique among the related enzymes. In contrast dases T from various bacteria [8]. Of these enzymes, a
crystal structure is available only for CPG2 [9], which isto the other related exopeptidases, PepV recognizes
and fixes the dipeptide backbone, while the side of prime interest due to the enzyme’s ability to cleave
the C-terminal Glu from folic (pteroylglutamic) acid andchains are not specifically probed and can vary, ren-
dering it a nonspecific dipeptidase. The cocrystallized folate analogs such as the chemotherapeutic agent
methotrexate.inhibitor illustrates the two roles of the two catalytic
zinc ions, namely stabilization of the tetrahedral inter- Further crystal structures of dinuclear zinc aminopep-
tidases are known for the M28 aminopeptidases frommediate and activation of the catalytic water molecule.
Aeromonas proteolytica (AAP)/Vibrio proteolyticus [7,
10] and Streptomyces griseus [11, 12] (clan MH) (seeIntroduction
Figure 2A), whose catalytic domains have been shown
to be related to CPG2 [9]. Further structures of dinuclearLactobacilli are organisms with multiple amino acid
auxotrophies making them critically dependent on their exopeptidases have been solved for leucyl aminopepti-
dases from bovine lens (LAP) [13–15] and E. coli (PepA)ability to efficiently degrade the milk protein casein [1].
Therefore, they possess a complex proteolytic system [16] (clan MF), the cobalt/zinc methionyl aminopepti-
Key words: dinuclear, dipeptidase, phosphinic inhibitor, zinc-metal-6 Correspondence: jozic@biochem.mpg.de (D.J.), maskos@biochem.
mpg.de (K.M.) lopeptidase, aminopeptidase, aminoacylase-1 family
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dases type I from E. coli [17] and type II from P. furiosus helices are packed in alternating orientation to the front
side of the major  sheet (Figure 1C). Only the dimeriza-[18] and the proline-specific aminopeptidase from E.
coli [19] (clan MG), which differ completely from the tion domain of CPG2 was found to be in part similar to
the lid domain of PepV in a database search. The eightfolding-type of the M20 and M28 catalytic domains, but
show related zinc binding geometries. Nevertheless, strands of the relatively flat major sheet are arranged
antiparallel to each other in the order sXI-sI-sX-sIX-sII-none of these enzymes is a real dinuclear dipeptidase.
Here, we report the crystal structure of the dinuclear sIV-sVI-sV. Both domains interact with a 500 A˚2 inter-
face which may be described as two lateral pillarspeptidase PepV, with a transition state analog, Asp
[PO2CH2]AlaOH, bound to the active site to elucidate bounding the active site (Figure 1A). The left pillar is
constituted by the two domain-connecting strands andthe substrate binding geometry and to identify residues
critical for substrate binding and catalysis. This structure surrounding side chains, while the right pillar is a mainly
hydrophobic contact between the domains, but with aexplains the preference of PepV for dipeptides, but also
allows explication of the different functions of the two solvent-exposed Glu95···Arg224 salt bridge. Between
these pillars, both domains form a deep cavity that ac-zinc ions.
commodates the active site and the S1 and S1 sub-
strate binding sites (nomenclature: P1, P2, etc. and P1,
Results P2, etc. represent the substrate residues in N- and
C-terminal direction from the scissile peptide bond,
Overall Structure while S1, S2, etc. and S1, S2, etc. correspond to sub-
468 of the 470 amino acid residues of PepV are defined sites on the proteinase). Altogether, residues provided
in electron density. The monomeric PepV molecule as- mainly by a number of loop segments and strands con-
sumes the shape of an extended ellipsoid, with approxi- tribute to the active site. Most of these are part of the
mate dimensions of 73  39  35 A˚. It consists of two catalytic domain, but several are also provided by the
distinct domains of almost equal size: the spherical lid domain (see below). The binding sites are mainly
/-type catalytic domain coordinates the zinc and pro- lined by the main chain segments of Gly413-Gly414-
vides the “catalytic” glutamate, while the brick-shaped Gly415-Thr416 (the “Gly bulge”), Asp177-Ala178 and
“lid” domain, likewise of an / fold, abuts the active Glu153-Glu154, and by a number of charged side chains
site region of the catalytic domain with its long, small coordinating the two catalytic zinc ions or otherwise
edge (Figure 1A). involved in the catalytic process (Figures 4 and 5).
The catalytic domain, formed by the first 185 and the
last 83 amino acid residues, consists essentially of a
twisted  sheet sandwiched between six  helices, and The Active Site Cavity
The active site cavity is comparable to a tunnel, whicha second smaller three-stranded  sheet on top of this
arrangement. The large sheet contains seven strands possesses two exits toward bulk water. A smaller essen-
tially hydrophobic exit of 3.5 A˚ diameter is directed to-arranged in the order s1-s2-s6-s3-s7-s9-s8, with s2 rep-
resenting the only antiparallel strand (Figure 1B). The ward the “front” side (in Figure 1A and to the lower left
side in Figure 4), while a wider, more polar exit of 5.5 A˚active site is located at the C-terminal end of the central
parallel  strands. Helix h4 is found on the back side of diameter points toward the “back” side on the molecule
(in Figure 1A and to the upper right side in Figure 4). In thethe central sheet, while helices h1, h2, h3, h5, and h6
cluster together on the front side, packed between the PepV structure, this tunnel is blocked by the phosphinic
inhibitor and some water molecules. The phosphinatemajor and the minor sheet. The surface-located N-ter-
minal helix h1 exhibits a sharp bend, while helices h3 group represents a tetrahedral transition state analog
of the scissile peptide bond of a bound substrate duringand h6 form the domain core. The N- and the C-terminal
ends are close to each other, opposite to the lid domain hydrolysis.
In this complex, His439 N2, the O1 oxygen of theand the active site. The PepV catalytic domain has a
fold similar to the catalytic domains of the related M20 phosphinate group, one of both oxygen atoms of the
‘bridging’ Asp119, and one carboxylate oxygen ofexopeptidase CPG2 [9] and the M28 exopeptidases AAP
[7] and SGAP [11] (Figure 3A). Sequence-based align- Glu154 coordinate zinc 1 in a first shell at an average
distance of 1.92 A˚. The other Glu154 carboxylate oxygenments of these catalytic domains with PepV show se-
quence identities of 28.1%, 19.1%, and 21%, respec- is placed more distantly (2.56 A˚) (for exact distances
see Figure 4A). In the inhibitor complex, the two catalytictively. An optimal superposition with these catalytic
domains reveals that 181, 145, and 154 of the 268 PepV zinc ions are placed 3.84 A˚ apart from each other. Zinc
2, in contrast, is more octahedrally coordinated, namelyresidues are topologically equivalent, with rms devia-
tions of 1.58, 1.35, and 1.73 A˚, respectively. Only 28.7%, by the two carboxylate oxygens of Asp177, His87 N2,
the other carboxylate oxygen of the bridging Asp119,17.3%, and 20.8% of these topologically equivalent resi-
dues are identical, however (Figure 2). and the N-terminal nitrogen and the other phosphinate
O2 oxygen of the bound inhibitor. The larger coordina-CPG2 is the only structural relative in which the poly-
peptide chain likewise exits the catalytic domain to form tion shell is reflected by an average distance of 2.13 A˚
and a larger variation (Figure 4A).another domain. The lid domain of PepV comprises the
202 residue segment Glu186-Gly387, inserted between It is notable that the peptide group between the bridg-
ing Asp119 and the adjacent residue Asp120 exhibits astrands s8 and s9 of the central  sheet of the catalytic
domain. It consists of an eight-stranded major  sheet, cis-conformation. Furthermore, the imidazole N1
atoms of His439 (zinc 1) and His87 (zinc 2) are furthera small two-stranded antiparallel sheet, two short ac-
companying extra strands, and four  helices. These  clamped to Asn217 O and Asp89 O, respectively.
Figure 1. Ribbon Diagrams of PepV
(A) Stereo view of PepV.  sheets of the cata-
lytic domain (bottom) and of the lid domain
(top) are highlighted in blue and red, respec-
tively. The phosphinic inhibitor Asp[PO2-
CH2]AlaOH is depicted as a stick model, and
the two catalytic zinc ions of the PepV active
center are represented as magenta spheres.
(B) Ribbon diagram of the catalytic domain
of PepV. Strands, helices, and zinc ions are
labeled in their order of appearance. The blue
and the gray ball indicate the end of the first
part and the beginning of the second part of
the catalytic domain, respectively.
(C) Ribbon diagram of the lid domain of PepV.
Strands and helices are labeled in their order
of appearance. The red and the gray ball indi-
cate the beginning and the end of the lid do-
main, respectively.
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Figure 2. Structure-Based Sequence Align-
ment of PepV with AAP and CPG2
The secondary structural elements of PepV
are shown above the amino acid sequence.
The strictly conserved residues are colored
in red, and similar residues are colored in
blue. Strands and  helices are indicated by
arrows and cylinders. Secondary structure el-
ements present in the catalytic domains of
AAP and CPG2 are shown in blue. Secondary
structure elements shared between the PepV
lid domain and the dimerization domain of
CPG2 are shown in red, while elements only
present in PepV are shown in beige. Zinc and
substrate binding residues are marked by
closed and open triangles, respectively. The
catalytic Glu153 is highlighted by a red tri-
angle.
The amino group of the N-terminal phosphinate inhibi- The following methylene group of the inhibitor, which
mimics an sp3 hybridized peptide nitrogen of a boundtor, besides interacting with its lone pair orbital with zinc
2, is directed approximately toward Asp177, forming dipeptide, is 3.13 A˚ away from the carbonyl oxygen of
Gly415 and from the “other” carboxylate oxygen of thetwo hydrogen bonds to its carbonyl group and to an
internal water molecule (Wat1; Figure 4A). The phosphi- catalytic Glu153. The C-terminal carboxylate group of
the inhibitor extends into the “carboxylate groove,”nate group “rides” on top of the (imaginary) zinc-zinc
line, with the oxygens located asymmetrically on either where it is tightly fixed by a network of hydrogen bonds
with surrounding polar groups (Figure 4). This carboxyl-side. The O2 oxygen is placed between both zinc ions
but is significantly closer to zinc 2, and is in addition in ate opposes the guanidyl group of Arg350 making two
short N···O charged hydrogen bonds, besides lateralhydrogen bond distance (2.56 A˚) to one of both carboxyl-
ate oxygens of the “catalytic” Glu153 (Figure 4A). Figure hydrogen bonds formed to Gly415 N and Asn217 N. The
Arg350 guanidyl group is further fixed through lateral3B shows the catalytic water molecule of CPG2 next to
the O2 oxygen of the PepV inhibitor, indicating that this hydrogen bonds to Gly413 O and Asn348 O (Figure 4).
The side chain of the AspI1 “residue” (“I” is used toO2 oxygen replaces presumably the catalytic water mol-
ecule in PepV. Besides its close interaction with zinc 1, refer to inhibitor residues) extends into the S1 cavity,
which in PepV is of medium size. This cavity is mainlythe other phosphinate oxygen O1 forms two hydrogen
bonds with an internal water molecule (Wat2) and with lined by hydrophobic groups such as Met436 and
Met438, which also close the cavity toward the smallerHis269 N2. This latter imidazole is further hydrogen
bonded to the Ser271 N through its N1 atom (Figure front exit (Figure 4B). The AspI1 side chain does not
completely fill this S1 cavity, and one of its carboxylate4B). His269 is therefore protonated at N2 and acts as
a hydrogen bond donor for the phosphinate O1 oxygen. oxygens is in hydrogen bond distance to the Gly415 O,
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Figure 3. Superposition of PepV with CPG2
and AAP
(A) Structures were superimposed using TOP.
Stereo view is shown of the superposition of
PepV (beige) with AAP (blue) and CPG2 (red)
after optimal fit of the catalytic domains.
(B) Stereo view of the two catalytic zinc ions,
the zinc binding residues, and the inhibitor
of PepV (beige) superimposed with the zinc
binding residues of AAP (blue) and CPG2
(red). Residues are numbered according to
the PepV sequence. The catalytic water mole-
cule of CPG2 is depicted in red (WAT).
suggesting that this carboxylate may be protonated at benzyl group would just fill the S1 cavity and could make
a number of favorable hydrophobic interactions. Thethe low pH (pH 5.6) of the crystal. However, a carboxylate
side chain does not fit optimally. The S1 pocket seems benzyl group of the C-terminal Phe2 residue, in contrast,
would extend into the S1 funnel-like exit where it couldrather to be shaped to accommodate medium-sized hy-
drophobic P1 side chains up to the size of a benzyl make many-fold contacts with surrounding groups but
also with bulk water molecules.group (see also Figure 5). The AlaI2 “side chain” points
into the funnel-shaped S1 pocket that opens toward
the larger back exit. This pocket is on one side hy- Discussion
drophobic but becomes increasingly polar toward the
exit due to several carbonyl groups, the Trp157 indole This structure analysis revealed that PepV is composed
of a catalytic domain and a lid domain, which interactmoiety, and the Glu380 side chain lining it (Figure 4B).
with each other and form an internal cavity at the inter-
face. This cavity, besides providing the zinc coordinat-Probable Substrate Binding
PepV shows a preference for large hydrophobic side ing residues, the two zinc ions, and the other substrate
recognizing and active residues, leaves just enoughchains, such as phenylalanine, at the N terminus of the
dipeptide. On the basis of this phosphinic acid PepV space for the bound Asp-Ala dipeptide-like phosphinate
inhibitor. The PepV catalytic domain has a fold similarcomplex, a Phe1-Phe2 dipeptide has been modeled into
the central cavity (Figure 5). For clarity, part of the stick to that previously found for the dinuclear carboxyl exo-
peptidase CPG2 [9] and for the dinuclear amino exopep-models covering the cavity in Figure 4B, as well as their
corresponding molecular surfaces, have been removed tidases AAP [7] and SGPA [11] (Figure 3A). This holds
even for the conserved cis-peptide bond betweenin Figure 5. The substrate main chain interacts with the
cavity residues similar to that observed for the phosphi- Asp119 and Asp120 (see Figure 4B), which seems to be
necessary to force the important zinc bridging carboxyl-nate inhibitor chain. Therefore, the amino group should
form the fifth ligand of zinc 2, and the carboxyl end ate into the correct geometry.
The active centers of the related dinuclear peptidasesshould be trapped in the hydrogen bond network domi-
nated by the Arg350 guanidyl group, both contributing CPG2 [9] and AAP [7] are organized similar to that of
PepV (Figure 3B). In both exopeptidases, zinc 1 pos-to the tightening of the substrate binding. The Phe1
Structure
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Figure 4. Stereo Close-Up View of the PepV
Active Site
(A) The phosphinic Asp[PO2CH2]AlaOH in-
hibitor is shown in blue (carbon atoms), red
(oxygens), dark blue (nitrogens), and purple
(phosphorus), while the surrounding PepV
residues are colored in beige (carbons). The
hydrogen bonding network and the zinc inter-
actions are shown as dotted lines, with dis-
tances depicted in angstroms. Two water
molecules that take part in the interaction
with the inhibitor are shown in blue.
(B) Electron density around the bound inhibi-
tor. The inhibitor (blue) and the PepV environ-
ment (beige) are shown as stick models. The
1.8 A˚ 2Fo-Fc simulated annealing omit map
has been contoured at 1.3 .
sesses identical ligands, namely a His imidazole group, due. A catalytic Glu residue is present in all related
peptidases.a Glu carboxylate group (in AAP less symmetrical), and
one of both carboxylate oxygens of the bridging Asp In this PepV-Asp[PO2CH2]AlaOH complex, both zinc
ions are placed 3.84 A˚ apart from each other, while theresidue. The zinc 2 site of AAP is virtually identical to
that of PepV, with a His imidazole group, a symmetrical zinc-zinc distances are slightly shorter (3.3 and 3.5 A˚)
in the nonliganded CPG2 and AAP. These intermetalAsp carboxylate, the other carboxylate oxygen of the
bridging Asp residue, and coordination sites for the sub- distances seem to increase, however, upon binding of
inhibitors, as exemplified for the AAP structures com-strate/inhibitor amino terminus and a water molecule/
O2 from a phosphinate mimetic. The equivalent site in plexed with a hydroxamic acid inhibitor (3.7 A˚) [20] or
with a phosphonic acid inhibitor (3.9 A˚) [10]. These dataCPG2 differs slightly in that the “symmetrical carboxyl-
ate” group stems from a Glu instead from an Asp resi- show that the active site can adapt to the respective
Figure 5. Stereo View of the Active Site Envi-
ronment of PepV with a Modeled Dipeptide
Surface representation of the active site.
Most of the lid domain and some other resi-
dues have been omitted for clarity. Only zinc
binding residues and some substrate binding
residues are shown in blue below and above
the semitransparent surface. The modeled
and energy-refined Phe1-Phe2 dipeptide is
shown as a stick model in beige. The location
of the Phe2 side chain in the S1 pocket is
somewhat arbitrary.
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entity bound. They further support the expectation that Table 1. Statistics of X-Ray Diffraction Data and Structure
the exact active site geometry will again slightly differ Refinement
in the presence of a “real” substrate and presumably
Data Set Edge Peak Remote
will change also in the course of a catalytic cycle.
Wavelength (A˚) 1.28210 1.28140 1.0500The more distant active site environment of both exo-
Resolution (A˚) 15.0–1.6 15.0–1.6 15.0–1.6peptidases differ, however, from that of PepV. In AAP,
Redundancy 4.38 4.36 2.16the Gly bulge covering the nonprimed site in PepV is
Unique reflections 62080 62044 62025
replaced by a disulfide-bridged Cys residue whose car- Completeness overall (%) 99.9 99.9 98.8
bonyl oxygen (as that of Gly415 O of PepV) points toward Outermost shell (%) 99.2 99.2 93.3
(1.63–1.60)the position of the leaving nitrogen group. The S1 subsite
I/ 22.69 23.48 16.15of AAP, in contrast, is more restricted in size than that
Rsyma (%) 7.6 6.8 6.1of PepV, while it is much larger in CPG2 (in particular
due to a different arrangement of the Asp177-Ala178- a Rsym 	 
hkl
i|Ihkl,i  Ihkl|/
|Ihkl|
Glu179 equivalent polypeptide segment), in agreement
with the different specificities of these exopeptidases
thereby promotes nucleophilic attack by the catalyticfor P1 residues.
water molecule. On the other hand, zinc 2 seems primar-The lid domain of PepV is unique among the exopepti-
ily to activate the catalytic water molecule and to pro-dases with respect to size and arrangement relative to
mote binding and hydrolysis. Therefore, the variousthe catalytic domain. Part of it (elements sI, sIX, sX, sXI,
tasks assigned to the single catalytic zinc of the mono-and h3 on the left side) resembles the much smaller
nuclear metallopeptidases might be divided effectively“dimerization domain” of CPG2, which, however, ex-
between the zinc ions of the dinuclear zinc peptidases,tends away from the (empty!) active site of the catalytic
which might enhance catalytic efficiency. However,domain [9]. Only in PepV, this extra domain folds over
these distinct tasks of the catalytic zinc ions overlap inthe active site assisting the catalytic domain to form
part in the activation of the catalytic water molecule anda cavity, which harbors the S1 and the S1 subsite.
the stabilization of the tetrahedral state.Therefore, the lid domain of PepV is uniquely involved
The apo form of the related AAP has been shown toin substrate specificity.
bind zinc 1 first, and this mononuclear APP has beenThe Asp-Ala phosphinate inhibitor bound in this PepV
found to still exhibit 80% of the maximal hydrolytic activ-complex mimics a bound dipeptide substrate at the
ity of the wild-type form [10]. Therefore, a single zincstage of tetrahedral adduct formation, with its sp3-meth-
ion together with the local environment indeed seemsylene group of the phosphinate group resembling the
to be capable of taking over most of the catalytic tasksprotonated amide group. Therefore, this structure
of the two zinc ions present in the native state of AAP.shows the expected interaction geometry for a dipeptide
PepV appears to be a canonically shaped andsubstrate when the catalytic water (or hydroxyl mole-
equipped dipeptidase. The N terminus of a bound dipep-cule) has attacked the carbonyl carbon of the scissile
tide substrate is fixed through the interaction with apeptide bond forming a tetrahedral adduct.
carbonyl oxygen, an internal water molecule (Wat1), andIn the free PepV molecule, as in other ligand-free exo-
zinc 2, through which the scissile peptide bond seemspeptidases such as CPG2 [9], we expect a fixed “bridg-
to be pulled in a proper position for catalysis. Preliminarying” water molecule to be placed between both zinc
model building and energy refinement experimentsions and close to the carboxylate group of the catalytic
show that a -Ala residue should be able to replace theGlu153, i.e., approximately at the position of the phos-
AspI1 residue of the inhibitor, requiring only a slightphinate inhibitor O2 atom (see Figure 3B). Upon binding
protuberance into the S1 cavity. This is in agreementof the dipeptide, this water molecule will be positioned
with the efficient cleavage of carnosine (-Ala-His) andbetween both zinc ions and the carbonyl carbon of the
other dipeptides with an N-terminal -Ala residue byscissile peptide bond. Both zinc ions, together with
PepV [5]. However, the cavity does not allow an N sub-Glu153, will activate the bridging water, generating a
stituent, particularly not a P2 residue. The S1 pocket ofhydroxyl group by proton transfer to Glu153. The car-
PepV is shaped and lined to optimally accommodatebonyl oxygen will be bound in a “oxyanion binding hole”
medium-sized hydrophobic side chains, and the spaceformed by zinc 1 and the imidazole group of His269,
around the P1-C atom is large enough to allow alsoresulting in the polarization of the carbonyl group and
the proper arrangement of small P1 residues with Dfacilitating the nucleophilic attack of the scissile bond
configuration, both in fair agreement with experimentalby the zinc-oriented hydroxyl group (positioned approxi-
results obtained in solution [5]. The equivalent but moremately at the O2 position) leading to a tetrahedral inter-
rigid site in AAP, in contrast, might not allow such amediate. This tetrahedral intermediate decays to the
variability, rendering it a real aminopeptidase restrictedproducts, the free amino acids, after one additional pro-
to peptide substrates with medium-sized P1 residues ofton transfer from the catalytic Glu153 carboxylate to the
L configuration. CPG2 lacks an equivalent of the Asp177amide nitrogen. His269, a component of the oxyanion
carbonyl group, which in PepV helps to fix the aminohole in PepV seems to have a counterpart in CPG2
group of the bound dipeptide. Therefore, CPG2 can bind(Tyr384), but none in AAP.
much larger P1 equivalents such as the pteroate moietyIn dinuclear zinc peptidases, the two catalytic zinc
of the predominant circulatory form of folate in mammalsions seem to have different tasks [10, 15]. Zinc 1 primar-
and its analogs used in cancer therapy such as metho-ily appears to facilitate substrate binding and, with
His269 N2, to polarize the scissile carbonyl group and trexate [9].
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Table 2. Crystal Structure and Refinement Statistics
Space group P212121
Cell dimensions (A˚) a 	 67.151, b 	 77.025, c 	 89.955
Volume fraction of protein (%) 55.24
Vm (A˚3/Da) 2.77
Total number residues 468
Total non-H atoms 3654
Number of water molecules 570
Number of zinc atoms 2
Number of inhibitor atoms 15
Temperature factors
Protein (A˚2) 13.566
Solvent (A˚2) 27.100
Metal (A˚2) 9.185
Inhibitor 12.836
Resolution range of reflections used (A˚) 15.0-1.8
Rfactor (%)a 17.43
Free Rfactor (%)a 20.46
Stereochemical ideality
Bond (A˚) 0.009
Angle 1.74
aRfactor 	 |Fo  Fc|/Fo, where Fo is the observed and Fc is the calculated structure factor amplitude. The Rfree was calculated for 10% of the
reflections excluded from the refinement.
Furthermore, the environment around the C terminus conformational variability is indicated by the observa-
tion that crystals of PepV in the absence of the inhibitorof the bound dipeptide mimetic of PepV seems to be
diffract badly and show a much higher mosaicity.adapted to fix a dipeptide, with the carboxylate group
Of particular importance in substrate binding and re-framed by an extended hydrogen bond network, with
lease seems to be the Gly bulge, which is also presentthe central Arg350 side chain and the Asn217 N pro-
in CPG2 (Figure 2A) and in SGAP (Gly-Asp-Gly), but isvided by the lid domain. In AAP, which lacks an equiva-
replaced in AAP by a more rigid disulfide bridge. Thislent to Arg350, the S1 region is open so that substrate
Gly bulge is fixed in the PepV complex but will presum-binding is not restricted to dipeptides but allows also
ably be more loosely arranged in the absence of a ligand.binding of C-terminally elongated substrates, rendering
This is also suggested by the crystal structure of CPG2,AAP a real aminopeptidase. Free CPG2 likewise, due to
in which this loop is about 0.5 A˚ displaced from the zincthe lack of a large lid domain, does not possess a direct
ions in comparison to the PepV structure, and in freeArg350 equivalent. However, model building studies in-
SGAP [11], where the equivalent Gly bulge is disordered.dicate that its Arg324 side chain is in a proper position
In addition, this Gly bulge of PepV is, through the Gly415to bind and fix the C-terminal Glu carboxylate group of
carbonyl group, able to orient the scissile peptide bondthe folate/methotrexate substrate. There is no indication
via hydrogen bonding to the scissile peptide amidethat the lid domain of CPG2 as a whole could move
group of a bound dipeptide substrate.toward the catalytic domain.
The degradation of carnosine (-Ala-His) via PepV-
The P1 side chain of the bound dipeptide in the PepV
like enzymes during bacterial infections might enhance
enzyme-substrate complex can be of any size and the destructive potential of bacteria, because carnosine
charge. Tripeptides, in order to bind into the PepV active is thought to act as a physiologically important buffer
site cavity with the first residue placed in S1, could only of zinc ions to avoid zinc-mediated injury. Such an injury
bind after a N-C rotation of approximately 120, what might take place on the basis of the selective inhibitory
would place the side chain in the carboxylate groove effect on N-methyl-D-aspartate NR1/NR2A receptors as
and the third residue in the back exit. However, no side well as the zinc-mediated effect on the generation of
chains of a natural amino acid would fit well into the reactive oxygen species within neurons [21]. Alterna-
carboxylate groove, and the third residue might not find tively, the protective effect of carnosine for neurons may
adequate binding partners. Nevertheless, certain hy- also arise from its antiglycating activity [22].
drophobic tripeptides have been found to be cleaved Since mammalian carnosinases such as human serum
by PepV [5], although these are few in number. carnosinase, which is reported to be a metalloprotease
Considering the very tight packing of the dipeptidyl [23], are not yet well characterized, it remains a specula-
phosphinate inhibitor in the PepV structure, and of the tive suggestion that the structure of PepV shows fea-
dipeptide substrate in the PepV model (Figure 5), it is tures also of mammalian enzymes.
clear that access of these peptides to the active site
cavity of PepV would benefit from a significant opening. Biological Implications
It is conceivable that even the whole lid domain might
move away form its site seen in the crystal structure to Lactobacilli are organisms that use the milk protein ca-
sein for their growth. Therefore, they have developed aallow easier substrate access and product egress. Some
Crystal Structure of PeptidaseV
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BW6 of DESY (Deutsches Elektronensynchrtron, Hamburg, Ger-complex proteolytic system to degrade casein to small
many) with wavelengths at the ZN-K absorption edges f (1.2821 A˚)peptides and amino acids. Their use as starter cultures
and f″ (1.2814 A˚) and one remote wavelength (1.05 A˚) using a MAR-for dairy fermentations makes these bacteria an impor-
Research image plate detector (MAR Research, Hamburg, Ger-
tant target for peptidase manipulation aimed at enhanc- many). The statistics of the MAD data sets are summarized in Table
ing the quality of dairy products. 1. Complete data sets were collected through contiguous rotation
ranges at a given wavelength before proceeding to the next wave-PepV is unique among its structural cognates, which
length. Rotation data were recorded in frames of 1 (high-resolutioninclude carboxypeptidases and aminopeptidases, in that
data to 1.6 A˚) and 2 (low-resolution data to 2.4 A˚), each through ait alone possesses a closed active site and is thus special-
contiguous angular range of 90 followed by another contiguousized for dipeptidase activity. The phosphinic inhibitor
range of 90 for measuring the Friedel pairs in inverse beam geome-
present in the active site shows how the C-terminal try. The data collected at different wavelengths were processed
interaction of the dipeptide is utilized for the specific with the programs DENZO and SCALEPACK [25], and scaled with
CAD and SCALEIT from the CCP4 package [26]. Two zinc positionsrecognition of dipeptides without sequence specificity.
were localized in anomalous difference Patterson maps and wereThe diversity of biochemical reactions performed by
refined with MLPHARE/CCP4 [26]. After solvent flattening and den-aminoacylase-1 family members supports the conclu-
sity modification (DM) [27], the initial 2.0 A˚ electron density mapsion that it is primarily the substrate binding pockets
was clearly interpretable and traced by a model built on Silicon
that determine which substrates are processed by a Graphics (Mountain View, CA) workstations using TURBO FRODO
dinuclear zinc active site. The X-ray structure of PepV [28]. Calculation of the electron density maps and crystallographic
refinement were performed with REFMAC/CCP4 [26] and X-PLORprovides a rational framework within which mutations
[29]. The refinement procedures included simulated annealing, posi-can be designed to engineer substrate specificity. Thus,
tional refinement, and restrained temperature factor refinement us-this structure will have a significant impact on both bio-
ing parameters of Engh and Huber [30] and maximum likelihoodtechnological and fundamental aspects of this type of
algorithms as provided by X-PLOR [29]. Finally, water molecules
enzyme. were inserted automatically and checked manually by inspection of
The degradation of carnosine by bacterial dipepti- the refinement, and individual temperatures factors were refined.
dases similar to PepV might also have pathological im- The final model was refined to an Rfactor of 17.4% (Rfree 20.4%) for
reflections from 15 to 1.8 A˚ (Table 2). The polypeptide chain is fullypact during bacterial infections. This hypothesis is
defined from Met1 to Glu468, with all main chain angles being inbased on the observation that carnosine can function as
fully or generously allowed regions (Procheck [31]).a buffer for zinc concentrations in tissues and, thereby,
Searches for related structures in the database were performed
helps to protect from zinc-mediated injury, especially in using the program TOP [32]. Sequence comparisons of the amino-
the brain. acylase-1 family were made using GCG [33]. Figures were drawn
with MOLSCRIPT [34], Raster3D [35], and GRASP [36].
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